AncestryDNA for Drug Testing: Get Pharmacogenetics From Your Ancestry Data

AncestryDNA gives you raw genetic data: the genotype calls from the genealogy chip it ran on your saliva, plus ethnicity and family-matching estimates. What it does not give you is anything about how those genes affect your medications, because AncestryDNA offers no health or drug-response reports at all. That is the gap Gene2Rx fills. Upload your AncestryDNA raw data file and Gene2Rx turns it into a pharmacogenetics report covering 110 medications, built on the same CPIC^[1] and FDA^[2] guidelines clinicians use. It runs in minutes, costs $5 for a starter report or $49 for the full report, needs no doctor's order, and never expires, because your DNA does not change. You paid for ethnicity estimates; the most medically useful data in that file is the pharmacogenetics you have not accessed yet.

AncestryDNA's genotyping chip reads hundreds of thousands of positions, including many of the pharmacogenetic variants used in clinical testing: the markers for CYP2D6, CYP2C19, CYP2C9, SLCO1B1, VKORC1, DPYD, and more are sitting in your raw data file. AncestryDNA simply does not interpret any of them for drug response, because health reporting is not part of its product. The genotypes are there; what is missing is the analysis that turns them into per-medication guidance.

Gene2Rx reads your raw data, calls your metabolizer phenotype for each pharmacogene (poor, intermediate, normal, rapid, or ultrarapid), and maps each phenotype to specific recommendations for 110 medications, with every recommendation traceable to its CPIC or FDA guideline. The report spans psychiatry (antidepressants, antipsychotics, ADHD medications), cardiology (clopidogrel, warfarin, statins, metoprolol), pain (codeine, tramadol), chemotherapy (capecitabine, fluorouracil), transplant, and gastrointestinal drugs. It is delivered in minutes, no new sample and no prescriber required.

Unlike 23andMe, which includes a narrow FDA-authorized pharmacogenetics section, AncestryDNA provides genealogy and ethnicity estimates only. There is no health service and no pharmacogenetic reporting of any kind, so the drug-response information in your raw data goes completely untouched. Gene2Rx fills a space that Ancestry leaves entirely empty: it reads the pharmacogenetic variants out of the same raw file and reports against 110 medications using CPIC and FDA dosing guidance.

AncestryDNA is a consumer genealogy product, not a clinical-grade assay, and the raw data download is labeled as not for medical use. Its chip reliably covers the common pharmacogenetic variants that drive the majority of actionable recommendations. It reads only the positions printed on the chip, so it does not detect structural variants such as gene duplications and deletions. That limit matters most for CYP2D6,^[3] where an extra gene copy can make someone an ultrarapid metabolizer and a deleted copy can leave almost no enzyme at all. For most prescribing questions your AncestryDNA data is a strong, low-cost starting point; for a high-stakes, one-time decision, a clinician may confirm a key result with a clinical-grade test.

Clinical pharmacogenetic tests like GeneSight run from a few hundred to a few thousand dollars, need a new DNA sample, and require a provider order. Because you already have AncestryDNA data, none of that applies: a Gene2Rx report is $5 for the starter tier or $49 for the full report, with no lab work to repeat. Your pharmacogenetic profile does not change over time, so a single report is a reference you will use for decades of prescribing decisions.

These are the main genes Gene2Rx reads out of your AncestryDNA data and what each one affects. The biology is the same no matter which data source you start from; what AncestryDNA provides is the raw genotype at these positions.

Your AncestryDNA raw data contains the genotypes for all of these genes; the only thing standing between that and actionable guidance is interpretation. Gene2Rx translates your genotypes into metabolizer phenotypes for each gene, then maps those phenotypes to specific medication recommendations anchored to CPIC^[1] and FDA^[2] guidelines, so the output reads the same way a clinical pharmacogenetic report would.

If you already have AncestryDNA data, there is little reason to wait: the data exists and the starter report is $5. It is most valuable if you are starting or already taking a medication with pharmacogenetic guidelines, if you have had side effects or poor response in the past, or if you simply want the information on file for future prescribing. Because your genotype never changes, one report serves you for life.

• 23andMe Pharmacogenetics: How to Get a Drug Response Report From Your Existing Data
• MyHeritage Pharmacogenetics: Use Your MyHeritage DNA for a Drug Response Report
• Nebula Genomics Pharmacogenetics: How to Get a Drug Response Report From Your WGS Data
• How Much Does a Pharmacogenetic Test Cost? 2026 Prices and Cheaper Alternatives
• Looking for a GeneSight Alternative? Here's the Short Answer
• Looking for a Genomind Alternative? Here's What to Know

No. AncestryDNA is a genealogy product: it gives you ethnicity estimates and family matches, with no health or drug-response reporting of any kind. The pharmacogenetic variants are in your raw data, but Ancestry never interprets them. Gene2Rx reads those variants from the same raw file and reports against 110 medications with CPIC and FDA guideline-based recommendations.

For the common variants, yes. AncestryDNA's genotyping chip reliably captures the pharmacogenetic markers driving the majority of actionable recommendations. A few caveats are worth knowing: it is a consumer-grade product whose raw data is labeled not for medical use rather than a clinical-grade assay, and like all genotyping chips it does not detect structural variants such as CYP2D6 gene duplications or deletions. For the most complete picture, whole genome sequencing resolves more (and Gene2Rx accepts that too), and a clinician may confirm a high-stakes result with a clinical-grade test.

Yes. Your DNA does not change, so any chip version works. Older versions cover slightly fewer variants, but the core pharmacogenetic markers have been included since early AncestryDNA chips.

Those work too. Gene2Rx accepts AncestryDNA, 23andMe, and MyHeritage raw data, plus VCF files from whole genome sequencing. The process is the same: download your raw data and upload it. WGS and VCF uploads carry a $15 surcharge because they take more processing.